Caspofungin Acetate For Injection
Caspofungin Acetate For Injection
Caspofungin Acetate For Injection
50 mg vial, 70 mg vial
Registration Number ANDA211263
Indications
1.Empirical Therapy for Presumed Fungal Infections in Febrile, Neutropenic Patients
2.Treatment of Candidemia and Other Candida Infections
3.Treatment of Esophageal Candidiasis
4.Treatment of Invasive Aspergillosis in Patients Who Are Refractory to or Intolerant of Other Therapies
product details
| Name | Caspofungin Acetate For Injection |
| Registration Number | ANDA211263 |
| Generic Name | Caspofungin Acetate |
| Territory | U.S.A. |
| Package | 50 mg vial, 70 mg vial |
| Indication | Empirical Therapy for Presumed Fungal Infections in Febrile, Neutropenic Patients Treatment of Candidemia and Other Candida Infections Treatment of Esophageal Candidiasis Treatment of Invasive Aspergillosis in Patients Who Are Refractory to or Intolerant of Other Therapies |
| Storage | Store refrigerated between 2-8℃ |
Adverse Reaction Contact
24 hour phone: +886-800-035-511
email : pharmacovigilance@ubi-pharma.com